SAN DIEGO, CA, Aug. 11, 2022 (GLOBE NEWSWIRE) — through NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Firm”), the first-ever publicly traded hashish firm in the USA that launched the world’s first-ever cannabis-derived nutraceutical merchandise, manufacturers, and provide chain, introduced at this time its pharmaceutical subsidiary, HM Pharma, has submitted a product file for its cannabidiol (CBD) merchandise after receiving Sanitary Authorization from ANVISA, Brazil’s Well being Regulatory Company.
Below ANVISA Normative 327/2019, this registration permits corporations similar to HM Pharma to bulk import uncooked extracts, remoted cannabinoids or completed merchandise in addition to manufacture and distribute hashish merchandise to pharmacies in Brazil.
“It is a massive accomplishment for our firm and nice information for the residents of Brazil,” mentioned Matheus Patelli, Managing Director of HM Pharma. “Submitting our file is the ultimate step to registering our product as a pharmaceutical product in Brazil enabling our firm to promote our merchandise in pharmacies. We hope to offer one other choice to entry CBD for these in want.”
Medical Marijuana, Inc. subsidiary HempMeds® Brasil was the primary firm to legally import merchandise to Brazil in 2015 using Brazil’s Compassionate Use legal guidelines. The compassionate use market in Brazil is flourishing and it’ll proceed to coexist with the medical market. HempMeds® Brasil, which is at the moment rising 75% quicker than the general Brazilian CBD market, and is the main firm in Brazil’s hashish trade, will proceed to function beneath the compassionate use mannequin, whereas HM Pharma will function beneath ANVISA Normative 327/2019.
“It’s large to see continued development and regulatory progress for our firm in Brazil,” mentioned Medical Marijuana, Inc. CEO Blake Schroeder. “We’re optimistic about our unimaginable ahead momentum into the pharmaceutical area, and we stay up for sharing extra thrilling updates on our new gross sales channels within the close to future.”
About Medical Marijuana, Inc.
We’re an organization of firsts®. Medical Marijuana, Inc. (MJNA) is a hashish firm with three distinct enterprise items within the non-psychoactive cannabinoid area: a worldwide portfolio of cannabinoid-based nutraceutical manufacturers led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality authorized non-psychoactive hashish merchandise derived from industrial hemp; and a cannabinoid-based scientific analysis and botanical drug improvement sector led by its pharmaceutical funding corporations and companions together with AXIM® Biotechnologies, Inc. and Neuropathix. Medical Marijuana, Inc. was named a high CBD producer by CNBC. Medical Marijuana, Inc. was additionally the primary firm to obtain historic import permits for CBD merchandise from the governments of Brazil, Mexico, Argentina, and Paraguay and is a frontrunner within the improvement of worldwide markets. The corporate’s flagship product Actual Scientific Hemp Oil has been utilized in a number of profitable scientific research all through Mexico and Brazil to grasp its security and efficacy.
Medical Marijuana, Inc.’s headquarters is in San Diego, California, and extra data is on the market at OTCMarkets.com or by visitingwww.medicalmarijuanainc.com. To see Medical Marijuana, Inc.’s company video, click on right here.
FORWARD-LOOKING DISCLAIMER
This press launch might comprise sure forward-looking statements and data, as outlined throughout the that means of Part 27A of the Securities Act of 1933 and Part 21E of the Securities Trade Act of 1934, and is topic to the Secure Harbor created by these sections. This materials incorporates statements about anticipated future occasions and/or monetary outcomes which can be forward-looking in nature and topic to dangers and uncertainties. Such forward-looking statements by definition contain dangers, uncertainties and different elements, which can trigger the precise outcomes, efficiency or achievements of Medical Marijuana, Inc. to be materially completely different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements haven’t been evaluated by the Meals and Drug Administration. This product will not be meant to diagnose, deal with, treatment, or stop any illness.
LEGAL DISCLOSURE
Medical Marijuana, Inc. doesn’t promote or distribute any merchandise which can be in violation of the USA Managed Substances Act.
CONTACT:
Public Relations Contact:
Kyle Porter
CMW Media
P. 858-221-8001
[email protected]
www.cmwmedia.com
Investor Relations Contact:
P. (858) 283-4016
[email protected]
